|
107年5月7日(星期一) Monday, May 7th, 2018
|
| 時間 |
議程內容Topics |
講者Speakers
|
|
8:30 ~9:00
|
Registration
|
|
9:00 ~9:30
|
Opening Remarks
|
莊偉哲 司長
科技部 生命科學研究發展司
Dr. Woei-Jer Chuang, Director General, Department of Life Science, Ministry of Science and Technology
曾宇鳳 教授
SPARK Taiwan生醫商品化計畫主持人
Prof. Y. Jane Tseng, Director
SPARK Taiwan Program, The Science and Technology Policy Research and Information Center (STPI), National Applied Research Laboratories (NARLabs)
|
|
9:30 ~ 10:30
|
Opening Keynote
How to identify unmet needs: The practice and case studies of valuable unmet need finding
|
Dr. Nancy Federspiel/
Associate Director, Stanford SPARK Translational Research Program
Executive Director, Global SPARK
曾宇鳳 教授
SPARK Taiwan生醫商品化計畫主持人
Prof. Y. Jane Tseng, Director
SPARK Taiwan Program, The Science and Technology Policy Research and Information Center (STPI), National Applied Research Laboratories (NARLabs)
|
|
10:30 ~ 11:00
|
茶敘Coffee Break
|
|
11:00 ~ 12:00
|
Opening Keynote
Innovation: From Asia to Global Market
|
Fumiaki Ikeno, M.D. /
Global Program Development Project Liaison, Stanford Biodesign Program
曾宇鳳 教授
SPARK Taiwan生醫商品化計畫主持人
Prof. Y. Jane Tseng, Director
SPARK Taiwan Program, The Science and Technology Policy Research and Information Center (STPI), National Applied Research Laboratories (NARLabs)
|
|
12:00 ~ 13:00
|
午餐Lunch
|
|
13:00 ~ 14:00
|
SESSION I
Pre-clinical Toxicology in New Drug Development
|
Dr. Michael Taylor PhD, DABT/ Founder, Nonclinical Safety Assessment
曾宇鳳 教授
SPARK Taiwan生醫商品化計畫主持人
Prof. Y. Jane Tseng, Director
SPARK Taiwan Program, The Science and Technology Policy Research and Information Center (STPI), National Applied Research Laboratories (NARLabs)
|
|
14:00 ~ 15:00
|
SESSION II
Early Stage IP strategy in New Drug Development
|
Meg Snowden/VP, Intellectual Property at Impax Laboratories
曾宇鳳 教授
SPARK Taiwan生醫商品化計畫主持人
Prof. Y. Jane Tseng, Director
SPARK Taiwan Program, The Science and Technology Policy Research and Information Center (STPI), National Applied Research Laboratories (NARLabs)
|
|
15:00 ~ 15:30
|
茶敘Coffee Break
|
|
15:30 ~ 17:00
|
Panel Discussion:
Breakthrough from academia /clinic to industry
曾宇鳳 教授
SPARK Taiwan生醫商品化計畫主持人
Prof. Y. Jane Tseng, Director, SPARK Taiwan
Dr. Nancy Federspiel
Associate Director, Stanford SPARK Translational Research Program
Executive Director, Global SPARK
Margaret M. Snowden, , J.D.
VP, Intellectual Property at Impax Laboratories
Dr. Michael Taylor
Founder, NonClinical Safety Assessment
Fumiaki Ikeno M.D.
Global Program Development Project Liaison,
Stanford Biodesign Program
|